SCHEMBL7070095

SCHEMBL7070095

CCOC(Cc1cc(Cl)ccc1OCc1cnc2ccc(OC)cc2c1OC(C)C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.38
PPARG P37231 5/20 0.38
PPARD Q03181 3/20 0.38
MAPT P10636 6/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
THRB P10828 1/20 0.37
KCNH2 Q12809 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 2/20 0.34
MRGPRX4 Q96LA9 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
NFKB1 P19838 1/20 0.34
HIF1A Q16665 1/20 0.34
GMNN O75496 1/20 0.34
APEX1 P27695 1/20 0.34
PMP22 Q01453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067676 0.89 MAPT (0.40) PPARAPPARGPPARDMAPTSMN1; SMN2
SCHEMBL7067917 0.89 PPARA (0.40) PPARAPPARGPPARDMAPTSMN1; SMN2
SCHEMBL7066784 0.87 PPARA (0.39) PPARAPPARGPPARDMRGPRX4
SCHEMBL7067911 0.86 PPARA (0.43) PPARAPPARGPPARDMAPTKMT2A
SCHEMBL7070221 0.85 MAPT (0.38) PPARAPPARGPPARDMAPTSMN1; SMN2
SCHEMBL7070094 0.85 PPARA (0.42) PPARAPPARGPPARDMAPTSMN1; SMN2
SCHEMBL7067668 0.85 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL7067722 0.85 PPARA (0.50) PPARAPPARGMAPTSMN1; SMN2THRB
SCHEMBL7066778 0.84 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL7072687 0.83 PPARA (0.39) PPARAPPARGPPARDMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed
EP-1266888-A1 QUINOLINE DERIVATIVES AND MEDICINAL USE THEREOF Mitsui Chemicals, Inc. (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA PPARA 3/4885PPARG 1/4885PPARD 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.